Webinar Replay

Estimands: Not just a statistical issue  

In this on demand webinar, Paul Terrill, Associate Principal of Strategic Consulting at Cytel,shares the bottom-line on estimands and discusses their implications for your trial's data collection, statistical analyses, and conclusions. Paul shares his guidance on managing the communication about estimands between multiple internal stakeholders as well as regulatory agencies, gaining internal buy-in, and ensuring that your trial demonstrates integrity in line with the ICH E9 addendum.

Key Learning Points

• Estimands and their role in clinical trials- the essentials
• Which stakeholders need to understand them and why?
• Why it is not just a statistical issue
• How do estimands impact:
  Internal understanding and agreements
  The clinical data collected
  The statistical analyses
  The conclusions from the study
  The Regulatory approval process
• How to facilitate early discussions with clinicians and regulators to harmonize trial objectives
• The consequences of not thinking about estimands
• Best practices for organizations

Audience

Medical
Clinical Development
Clinical Operations

Watch Webinar

Complete the form to access the webinar and slides